Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,325.61
-37.1145-1.10%
Number of Gainers:9
Number of Losers:20
Number of Flat:2
PE:- -
High:3,365.42
Open:3,365.42
Low:3,323.31
Close:3,362.73
Volume:417.78M
Turnover:44.95B
Market Cap:6.26T
Float Cap:5.49T

Loading ...

Goldman Sachs Voting Rights in Hypoport Slip to 4.95% from 5.09%

Reuters
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Morgan Stanley Boosts Stake in SG Micro with 110,900 Share Purchase at Roughly HK$106.19 Each

Stock News
·
Aug 19

Goldman Sachs Boosts Stake in Asymchem with Recent Share Purchase

Stock News
·
Aug 19

JPMorgan Expands Stake in DAJIN with Latest Share Purchase

Stock News
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

META, MSFT and AMZN Face Rising Costs and Delays as AI Data Center Backlash Grows

TIPRANKS
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Unified Communications Platform Helps Businesses Simplify Communications Across Sparklight Service Areas

GlobeNewswire
·
Aug 19

Goldman Sachs Remains a Hold on Natura Cosmeticos SA (NATU3)

TIPRANKS
·
Aug 19

Magazine Luiza S.A. (MGLU3) Receives a Hold from Goldman Sachs

TIPRANKS
·
Aug 19

Skoda CEO Says VW Aims to Finalise India Partner This Year to Share Risk, Drive Growth

Reuters
·
Aug 19

Merck Shares Rise 1.9% Premarket

THOMSON REUTERS
·
Aug 19

AI and Robotics are a Battleground for U.S. and China. This is the Best Bet.

Dow Jones
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Safety Profiles of Intismeran and Keytruda in Trial were Consistent with Prior Reported Studies for the Combination

THOMSON REUTERS
·
Aug 19

Merck: Phase 3 Interpath-001 Trial of Intismeran Autogene Plus Keytruda Met Primary Endpoint of Recurrence Free Survival

THOMSON REUTERS
·
Aug 19